NEW

Every industry has its bad actors.  In the case of pharmaceutical companies the bad actors fall into two categories; those…

Pfizer announced WSJ: Pfizer Plans to Abandon Heart-Drug Development  that they are giving up on the Cardiovascular business…

This week Senator Grassley sent some more letters, Grassley asks NIH to account for employment of expert advisor, this time he is…

In a move to give the public more transparency around physician payments and grants Merck announced that starting in October,…

Several months ago, I met a young woman who was the chief lobbyist for a well know anti-industry group.  In our discussion…

In a move to provide greater transparency of payments for consulting and speaking to physicians, Eli Lilly Announced today that…

If you are one of the world’s premier biostatisticians and have a Sir before your name you can pretty much tell Congress thanks…

"Every last dime spent on advertising is passed on to the consumer." Senator Herbert Kohl, Wisconsin, stated at a…

Senator Grassley is putting the pressure on the National Institutes of Health to beef up their enforcement of disclosure rules…

ACCME Call for Comment: Organizations Respond The ACCME recently stated in a letter to NAAMECC: ACCME will make public without…